1-(1-Methylethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 100mg

(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride, 95%, 10g

Copper(II) Dibutyldithiocarbamate>98.0%(T)25g

8-methyl-4-(2-methylbenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

(S)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 1g

8-Bromo-3-methylimidazo[1,2-a]pyridine, 97%, 5g

[3-(Diethylamino)propyl]trimethoxysilane>97.0%(GC)(T)25mL

2-(Tetrahydropyran-4-yl)-2H-pyrazol-3-ylamine, 97%, 10g

z-tyr-ome, 95.0%, 100g

tert-Butyl (R)-(1-cyclopropyl-2-hydroxyethyl)carbamate, 97%, 100mg

3-Methylcytidine, 99.85%, 50mg

2-((2-Amino-6-chloro-9H-purin-9-yl)methyl)-4,4-diethoxybutan-1-ol, 98%, 250mg

1-ethyl-4-methyl-1H-pyrazol-5-amine, 95.0%, 5g